ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP PRSYM
    • 2016-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • Register
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstracts tagged "Lupus and belimumab"

  • Abstract Number: 2650 • 2018 ACR/ARHP Annual Meeting

    Efficacy, Safety, and Predictor of Response to Belimumab in a Large Nationwide Cohort Study of Patients with Active Systemic Lupus Erythematosus

    Luca Iaccarino1, Francesca Saccon1, Alessandro Mathieu2, Matteo Piga3, Angela Ceribelli4, Carlo Selmi5, Paolo Cardinaletti6, Armando Gabrielli7, Andrea Di Matteo8, Rossella De Angelis9, Paola Faggioli10, Antonella Laria11, Micaela Fredi12, Francesca Regola13, Angela Tincani12, Laura Andreoli14, Giulia Pazzola15, Carlo Salvarani15, Francesco Puppo16, Ottavia Magnani16, Marcella Prete17, Elisa Gremese18, Maria Gerosa19, Tania Ubiali20, Enrica Bozzolo21, Valentina Canti21, Vito Racanelli17, Fabrizio Conti22, Fulvia Ceccarelli23, Elena Bartoloni24, Roberto Gerli25, Antonio Lobasso26, Amato de Paulis27, Ginevra De Marchi28, Salvatore De Vita29, Alessandra Bortoluzzi30, Marcello Govoni30, Francesco Benvenuti31, Margherita Zen32, Marta Mosca33, Chiara Tani34, Maurizio Rossini35, Giovanni Orsolini35, Salvatore Scarpato36, Ernico Brunetta37, Aurora Zumbo38, Giacomo Tanti39 and Andrea Doria40, 1Department of Medicine-DIMED, University of Padova, Padova, Italy, 2University of Cagliari, Cagliari, Italy, 3Unit and Chair of Rheumatology, University Hospital of Cagliari, Cagliari, Italy, 4Rheumatology and Clinical Immunology, Humanitas Research Hospital, Rozzano (MI), Italy, 5Rheumatology and Clinical Immunology Unit, Humanitas Research Hospital, Rozzano (MI), Italy, 6University of Ancona, Ancona, Italy, 7Univeristy of Ancona, Ancona, Italy, 8Polytechnic University of Marche, Rheumatology Clinic, Jesi, Italy, 9Polytechnic University of Marche, Rheumatology Clinic, jesi, Italy, 10Hospital of Legnano, Legnano, Italy, 11Hospital of Magenta, Magenta, Italy, 12Rheumatology and Clinical Immunology, Spedali Civili and University of Brescia, Brescia, Italy, 13University of Brescia, Brescia, Italy, 14Department of Clinical and Experimental Sciences, Spedali Civili and University of Brescia, Brescia, Italy, Rheumatology and Clinical Immunology, Spedali Civili and University of Brescia, Brescia, Italy, 15University of Reggio Emilia, Reggio Emilia, Italy, 16University of Genova, Genova, Italy, 17University of Bari, Bari, Italy, 18Division of Rheumatology, Fondazione Policlinico Universitario A.Gemelli IRCCS, Catholic University of the Sacred Heart, Rome, Italy, 19Istituto Ortopedico Gaetano Pini, University of Milan, Milano, Italy, 20Istituto Gaetano Pini, University of Milano, Milano, Italy, 21Hospital San Raffaele, Milano, Italy, 22Rheumatology Unit, Department of Internal Medicine and Medical Specialties, Sapienza University of Rome, Rome, Italy, 23UO Complessa Reumatologia, Policlinico Umberto I Università Sapienza di Roma, Rome, Italy, 24Rheumatology Unit, University of Perugia, Perugia, Italy, 25Department of Medicine, Rheumatology Unit, University of Perugia, Perugia, Italy, 26University Federico II of Napoli, Napoli, Italy, 27Department of Translational Medical Sciences and Center for Basic and Clinical Immunology Research (CISI), University of Naples Federico II, Naples, Italy, 28Hospital/University of Udine, Udine, Italy, 29Rheumatology Clinic, Academic Hospital S. M. della Misericordia, Medical Area Department, University of Udine, Italy, Udine, Italy, 30UOC of Rheumatology, University Hospital S. Anna, Cona Ferrara, Italy, 31University of Padova, Padova, Italy, 32Division of Rheumatology, University of Padova, Padova, Italy, 33Rheumatology Unit, University of Pisa, Pisa, Italy, 34Univeristy of Pisa, Pisa, Italy, 35Rheumatology Unit, University of Verona, Verona, Italy, 36Hospital of Salerno, Salerno, Italy, 37Humanitas Hospital, Milano, Italy, 38Humnaitas Hospital, Milano, Italy, 39Catholic University of the sacred hearth, Roma, Italy, 40University and Azienda Ospedaliera of Padova, Padova, Italy

    Background/Purpose: To investigate effectiveness, safety, and predictors of response to belimumab in patients with active SLE in clinical practice setting. Methods: Four hundred and one…
  • Abstract Number: 780 • 2016 ACR/ARHP Annual Meeting

    Belimumab Use in African-American Patients in an U.S. Academic Medical Center

    Paloma Alejandro1, Anjani Pillarisetty2 and Christopher E. Collins3, 1Rheumatology, MedStar Washington Hospital Center/Georgetown University Medical Center, Washington, DC, 2Internal Medicine, MedStar Washington Hospital Center/Georgetown University Medical Center, Washington, DC, 3MedStar Washington Hospital Center/Georgetown University Medical Center, Washington, DC

    Background/Purpose: Belimumab is an anti-BAFF monoclonal antibody approved for the treatment of auto-antibody positive patients with SLE. In two large phase 3 clinical trials, belimumab…
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Convergence: Where Rheumatology Meets. All Virtual. November 5-9.

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2021 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
This site uses cookies: Find out more.